Sun Global Logo SUN GLOBAL
Get Quote Chat with our sales team
AOD-9604
HGH Fragment
99.1%
Purity
MOQ
Contact for MOQ
Lead Time
3~5 day
Storage
-20°C

Factory direct peptide supply

AOD-9604

HGH Fragment 177-191

Available Sizes

Selected: 2 mg/vial (10 vials)
Contact for pricing
Ready for quotation Contact us and send this product name.
Send inquiry / request COA

For faster quotation, include purity, quantity, packaging request and target market.

99%+HPLC purity options
COABatch documents
3-5DFast preparation

AOD-9604 is a modified fragment of human growth hormone (hGH) corresponding to amino acids 177-191 of the hGH sequence. Unlike full hGH, AOD-9604 specifically targets fat metabolism without the side effects associated with full hGH, such as insulin resistance or cell proliferation. It stimulates lipolysis and inhibits lipogenesis, making it valuable for body composition research.

Key Benefits

Selective lipolytic activity without growth-related side effects in research
No impact on blood glucose or IGF-1
Stimulates lipolysis in adipose tissue
Safe metabolic profile in research

Product Description

AOD-9604 is a modified fragment of human growth hormone (hGH) corresponding to amino acids 177-191 of the hGH sequence. Unlike full hGH, AOD-9604 specifically targets fat metabolism without the side effects associated with full hGH, such as insulin resistance or cell proliferation. It stimulates lipolysis and inhibits lipogenesis, making it valuable for body composition research.

CAS Number
221231-10-3
Appearance
White lyophilized powder
Solubility
Soluble in water or bacteriostatic water at ≥1 mg/mL
Storage
-20°C for long-term; 4°C for up to 6 weeks

Amino Acid Sequence

Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe-NH₂

Molecular Information

Molecular FormulaC₇₈H₁₂₃N₂₃O₂₃S₂
Molecular Weight1817.12 Da
Purity MethodHPLC & MS

Technical Specifications

Product NameAOD-9604
Alias / Trade NameHGH Fragment 177-191
CAS Number221231-10-3
Molecular FormulaC₇₈H₁₂₃N₂₃O₂₃S₂
Molecular Weight1817.12 Da
Purity99.1% (by HPLC & MS)
AppearanceWhite lyophilized powder
SolubilitySoluble in water or bacteriostatic water at ≥1 mg/mL
Storage Conditions-20°C for long-term; 4°C for up to 6 weeks
Salt FormAcetate
Minimum Order QuantityContact for MOQ
Available Sizes2 mg/vial, 5 mg/vial

Amino Acid Sequence

Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe-NH₂

Certificate of Analysis

Batch-specific testing results

COA Report
Note: A batch-specific Certificate of Analysis (COA) is provided with every order. Contact us to request a sample COA for this product.

Factory supply workflow

From product name to confirmed quotation.

Send the product name, selected strength, quantity, purity requirement, packaging style and destination market. The sales team can confirm stock, MOQ, batch COA, HPLC/MS files, lead time and private label options.

01Confirm product

Product name, mg/vial, vial count and target quantity.

02Verify documents

Batch COA, HPLC, MS, appearance and storage conditions.

03Quote & packaging

Factory price, MOQ, label, box and custom brand support.

04Dispatch

Fast preparation with export support and shipment updates.

Related Research

Peer-reviewed scientific literature on AOD-9604 from PubMed, NEJM, The Lancet, and other authoritative sources.

1
Preclinical2001

Metabolic Effects of AOD9604: A Modified Fragment of Human Growth Hormone

Heffernan M, Summers RJ, Thorburn A, et al.

Endocrinology, 142: 920–927 (2001)

Key Finding

AOD9604 significantly reduced body fat in obese animals through direct stimulation of lipolysis and inhibition of lipogenesis, with no effect on blood glucose levels or IGF-1 concentrations, demonstrating a clean metabolic profile.

2
Preclinical2000

Long-Term Treatment with AOD9604 Does Not Promote Insulin Resistance or Adverse Metabolic Effects

Ng FM, Sun J, Sharma L, et al.

Journal of Endocrinology, 164: R1–R6 (2000)

Key Finding

Unlike full-length hGH, AOD9604 did not induce insulin resistance, hyperglycemia, or elevated IGF-1 levels during long-term treatment, while still producing significant reductions in adipose tissue mass.